Source: International Congress 2014 – Cell biology 2014
Disease area: Interstitial lung diseases

Abstract

Bleomycin (BLM)-induced pulmonary fibrosis, a side-effect of BLM therapy, is associated with pulmonary immune cell infiltration, which may contribute to fibrogenesis. Previous work suggests BLM may induce endothelial cell (EC) adhesion molecule and cytokine expression which may recruit leukocytes. However, the full profile of adhesion molecules and cytokines expressed by ECs treated with physiological BLM concentrations is uncertain; this work aims to characterise this profile.Adhesion molecule and cytokine expression by BLM-treated HUVECs was assessed by flow cytometry and ELISA, and confirmed by qPCR. Whether physiological TNF-a concentrations “primed” HUVECs and increased adhesion molecule expression was also assessed. HUVECs were also treated with etoposide, doxorubicin, and carboplatin, to determine whether observed effects were unique to BLM.HUVECs treated with BLM were seen to express higher levels of ICAM-1, VCAM-1, E-selectin, IL-8, and MCP-1. qPCR results confirmed that expression was regulated at a transcriptional level, suggesting BLM is not a cytokine secretagogue. However, co-treatment with TNF-a and BLM did not impact adhesion molecule expression. Further, only etoposide increased E-selectin, ICAM-1, and IL-8 expression, suggesting BLM is not unique in inducing an inflammatory phenotype in HUVECs.These results suggest the effects of BLM on ECs may induce pulmonary immune cell recruitment, as may the effects of etoposide, which has also been associated with lung fibrosis. Future work will assess the functional relevance of this expression and whether pulmonary microvascular ECs respond to BLM in a similar fashion.

Rating:

Share or cite this content

Citations should be made in the following way:
J. Williamson, L. Sadofsky, J. Greenman, S. Hart (Kingston upon Hull, United Kingdom). A potential role for endothelial adhesion molecules and cytokines in chemotherapy-induced lung fibrosis. Eur Respir J 2014; 44: Suppl. 58, 3841

Member's Comments

No comment yet.

Related content which might interest you: Modulation of neutrophil functionalities by indacaterol and their relevance for chronic lung diseases Source: International Congress 2014 – Translational studies in COPD Year: 2014 Crosstalk between lung fibroblasts and T-lymphocytes: Implications for anti-viral responses in chronic lung disease Source: Annual Congress 2013 –Asthma: new mechanisms and markers Year: 2013 Mast cells and fibroblasts work in concert to aggravate pulmonary fibrosis: Role of transmembrane SCF and PAR-2/PKCalpha/Raf-1/p44/42 signaling pathway Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 The role of chemokine receptors in the aberrant migration of COPD neutrophils Source: International Congress 2014 – Cell biology 2014 Year: 2014 KCa3.1 mediates alphaSMA expression in human lung myofibroblast via the Smad2/3 and TGFbeta1 signalling pathway Source: International Congress 2014 – Cell biology 2014 Year: 2014 Phenotypes of alveolar macrophages in normal human lung and their polarization with disease Source: International Congress 2014 – New insights into monocyte and macrophage biology Year: 2014 Differential VEGF signalling in the lung Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013 Smoking alters alpha1-antitrypsin in alveolar macrophages possibly promoting misfolding Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases Year: 2014 Evidence for a novel kit adhesion domain mediating human mast cell adhesion to structural airway cells Source: International Congress 2014 – Cell biology 2014 Year: 2014 Metformin inhibits TGF-b-induced myofibroblast differentiation through AMPK activation Source: International Congress 2014 – Cell biology 2014 Year: 2014 Allergic asthma induce opposite changes in the expression of caveolin-1 and cavin-2 in airway and vascular pulmonary smooth muscle Source: International Congress 2014 – Animal models: asthma, COPD and beyond Year: 2014 Potential role of SPARC, a downstream mediator of TGF-b in chronic airways disease Source: International Congress 2015 – Airway remodelling: recent developments Year: 2015 TNF-a induces cPLA2 expression via Jak2/PDGFR-dependent Elk-1/p300 activation in human lung epithelial cells Source: International Congress 2014 – Mechanistic studies of the airway epithelium Year: 2014 Expression of CX3CL1 and CX3CR1 in human asthmatic lung in relation to cell survival Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 Lipoxin (LXA4) as a novel therapy for idiopathic pulmonary fibrosis Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 Differential sensitivity of subsets of monocyte-derived macrophages to apoptosis; its impact on lung inflammation Source: International Congress 2014 – New insights into monocyte and macrophage biology Year: 2014 Uncoupling the pro-fibrotic effects of TGF-beta1 versus tissue hardening in lung fibroblasts Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 CEACAM6-high airway neutrophils and epithelial cells are a feature of severe asthma Source: International Congress 2015 – Translational studies in airway cell biology Year: 2015 MiR-31 regulates IRF-1 function in cystic fibrosis epithelial cells Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine Year: 2014 Proteasome function in lung fibrosis Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013